These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32488576)

  • 1. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E; Li X; He S; Li X; He S
    Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
    Gong T; Xu J; Heng B; Qiu S; Yi B; Han Y; Lo ECM; Zhang C
    J Dent Res; 2019 Jul; 98(7):803-812. PubMed ID: 31017515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
    EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease.
    Yang D; Jin C; Ma H; Huang M; Shi GP; Wang J; Xiang M
    Angiogenesis; 2016 Jul; 19(3):297-309. PubMed ID: 27216867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.
    Taylor AC; Mendel TA; Mason KE; Degen KE; Yates PA; Peirce SM
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5462-70. PubMed ID: 22789927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
    Zhang JS; Wang YZ; Hu YQ; Lin F; Gao D; Song J; Kaptchuk TJ; Chen KJ
    Chin J Integr Med; 2016 Aug; 22(8):605-10. PubMed ID: 27299459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis.
    Yuan K; Hong TM; Chen JJ; Tsai WH; Lin MT
    Blood; 2004 Aug; 104(4):1025-33. PubMed ID: 15126321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J; Wang YJ; Liu L; Zhao YL
    J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
    Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
    Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
    Sturz A; Bader B; Thierauch KH; Glienke J
    Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
    Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
    EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of angiogenic signaling pathways in hemangioblastoma.
    Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
    Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
    Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
    Elife; 2020 Sep; 9():. PubMed ID: 32897857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
    Yang C; Guo Y; Jadlowiec CC; Li X; Lv W; Model LS; Collins MJ; Kondo Y; Muto A; Shu C; Dardik A
    J Surg Res; 2013 Jul; 183(1):478-86. PubMed ID: 23394931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
    Davies MH; Stempel AJ; Hubert KE; Powers MR
    Dev Dyn; 2010 Jun; 239(6):1695-707. PubMed ID: 20503366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
    FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
    Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.